This is a double blind placebo controlled randomized trial to determine whether giving MLC901 for 6 months will improve the outcomes in a adult patients with moderate traumatic brain injury.
This study wants to evaluate whether MLC901 will help improve the condition of adult patients with moderate traumatic brain injury.